nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP2A6—esophageal cancer	0.749	1	CbGaD
Norfloxacin—Guillain-Barre syndrome—Methotrexate—esophageal cancer	0.00402	0.0353	CcSEcCtD
Norfloxacin—Dysphasia—Capecitabine—esophageal cancer	0.00359	0.0315	CcSEcCtD
Norfloxacin—Joint stiffness—Capecitabine—esophageal cancer	0.0026	0.0228	CcSEcCtD
Norfloxacin—Polyneuropathy—Capecitabine—esophageal cancer	0.00241	0.0211	CcSEcCtD
Norfloxacin—Pruritus genital—Capecitabine—esophageal cancer	0.00188	0.0165	CcSEcCtD
Norfloxacin—Taste metallic—Methotrexate—esophageal cancer	0.00184	0.0161	CcSEcCtD
Norfloxacin—Serum creatinine increased—Cisplatin—esophageal cancer	0.00173	0.0152	CcSEcCtD
Norfloxacin—Proctalgia—Capecitabine—esophageal cancer	0.00167	0.0147	CcSEcCtD
Norfloxacin—Haematocrit decreased—Methotrexate—esophageal cancer	0.00157	0.0138	CcSEcCtD
Norfloxacin—Platelet count decreased—Capecitabine—esophageal cancer	0.00132	0.0116	CcSEcCtD
Norfloxacin—Myoclonus—Capecitabine—esophageal cancer	0.0013	0.0114	CcSEcCtD
Norfloxacin—Serum creatinine increased—Capecitabine—esophageal cancer	0.00128	0.0112	CcSEcCtD
Norfloxacin—Raised liver function tests—Methotrexate—esophageal cancer	0.00126	0.0111	CcSEcCtD
Norfloxacin—Lomefloxacin—ABCC2—esophageal cancer	0.00125	0.404	CrCbGaD
Norfloxacin—Tenderness—Cisplatin—esophageal cancer	0.00122	0.0107	CcSEcCtD
Norfloxacin—Aphasia—Capecitabine—esophageal cancer	0.00121	0.0106	CcSEcCtD
Norfloxacin—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.00119	0.0104	CcSEcCtD
Norfloxacin—Dysarthria—Cisplatin—esophageal cancer	0.00112	0.00987	CcSEcCtD
Norfloxacin—Torsade de pointes—Capecitabine—esophageal cancer	0.00112	0.00981	CcSEcCtD
Norfloxacin—Hearing impaired—Cisplatin—esophageal cancer	0.00112	0.00981	CcSEcCtD
Norfloxacin—Blister—Capecitabine—esophageal cancer	0.00109	0.00955	CcSEcCtD
Norfloxacin—Ofloxacin—ABCC2—esophageal cancer	0.00107	0.346	CrCbGaD
Norfloxacin—Body temperature increased—Carboplatin—esophageal cancer	0.00102	0.00898	CcSEcCtD
Norfloxacin—Tingling sensation—Capecitabine—esophageal cancer	0.000976	0.00856	CcSEcCtD
Norfloxacin—Aphasia—Methotrexate—esophageal cancer	0.0009	0.0079	CcSEcCtD
Norfloxacin—Proteinuria—Capecitabine—esophageal cancer	0.000893	0.00783	CcSEcCtD
Norfloxacin—Protein urine present—Capecitabine—esophageal cancer	0.00088	0.00772	CcSEcCtD
Norfloxacin—Deafness—Cisplatin—esophageal cancer	0.000863	0.00757	CcSEcCtD
Norfloxacin—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000856	0.00751	CcSEcCtD
Norfloxacin—Lacrimation increased—Capecitabine—esophageal cancer	0.000851	0.00747	CcSEcCtD
Norfloxacin—Dysarthria—Capecitabine—esophageal cancer	0.000829	0.00727	CcSEcCtD
Norfloxacin—Hearing impaired—Capecitabine—esophageal cancer	0.000824	0.00723	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000798	0.007	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000784	0.00688	CcSEcCtD
Norfloxacin—Irritability—Cisplatin—esophageal cancer	0.000737	0.00647	CcSEcCtD
Norfloxacin—Blood creatinine increased—Cisplatin—esophageal cancer	0.000724	0.00635	CcSEcCtD
Norfloxacin—Mouth ulceration—Capecitabine—esophageal cancer	0.000709	0.00622	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000705	0.00619	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000695	0.0061	CcSEcCtD
Norfloxacin—Cramp muscle—Cisplatin—esophageal cancer	0.000695	0.0061	CcSEcCtD
Norfloxacin—Proteinuria—Methotrexate—esophageal cancer	0.000664	0.00583	CcSEcCtD
Norfloxacin—Sleep disorder—Capecitabine—esophageal cancer	0.000658	0.00577	CcSEcCtD
Norfloxacin—Protein urine present—Methotrexate—esophageal cancer	0.000655	0.00575	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000655	0.00574	CcSEcCtD
Norfloxacin—Pancreatitis—Cisplatin—esophageal cancer	0.000654	0.00574	CcSEcCtD
Norfloxacin—Photosensitivity—Capecitabine—esophageal cancer	0.000648	0.00569	CcSEcCtD
Norfloxacin—Swelling—Capecitabine—esophageal cancer	0.000645	0.00566	CcSEcCtD
Norfloxacin—Deafness—Capecitabine—esophageal cancer	0.000636	0.00558	CcSEcCtD
Norfloxacin—Hepatic failure—Capecitabine—esophageal cancer	0.000634	0.00556	CcSEcCtD
Norfloxacin—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000631	0.00553	CcSEcCtD
Norfloxacin—Eye pain—Capecitabine—esophageal cancer	0.000631	0.00553	CcSEcCtD
Norfloxacin—Dysarthria—Methotrexate—esophageal cancer	0.000617	0.00542	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000603	0.00529	CcSEcCtD
Norfloxacin—Vasculitis—Methotrexate—esophageal cancer	0.000598	0.00525	CcSEcCtD
Norfloxacin—Dermatitis bullous—Capecitabine—esophageal cancer	0.000596	0.00523	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000587	0.00515	CcSEcCtD
Norfloxacin—Arthritis—Capecitabine—esophageal cancer	0.000586	0.00514	CcSEcCtD
Norfloxacin—Renal failure—Cisplatin—esophageal cancer	0.000585	0.00513	CcSEcCtD
Norfloxacin—Myocardial infarction—Cisplatin—esophageal cancer	0.000583	0.00512	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000583	0.00512	CcSEcCtD
Norfloxacin—Stomatitis—Cisplatin—esophageal cancer	0.00058	0.00509	CcSEcCtD
Norfloxacin—Conjunctivitis—Cisplatin—esophageal cancer	0.000579	0.00508	CcSEcCtD
Norfloxacin—Diplopia—Capecitabine—esophageal cancer	0.000569	0.00499	CcSEcCtD
Norfloxacin—Osteoarthritis—Capecitabine—esophageal cancer	0.000569	0.00499	CcSEcCtD
Norfloxacin—Irritability—Capecitabine—esophageal cancer	0.000543	0.00477	CcSEcCtD
Norfloxacin—Ataxia—Capecitabine—esophageal cancer	0.000535	0.0047	CcSEcCtD
Norfloxacin—Blood creatinine increased—Capecitabine—esophageal cancer	0.000533	0.00468	CcSEcCtD
Norfloxacin—Mouth ulceration—Methotrexate—esophageal cancer	0.000528	0.00463	CcSEcCtD
Norfloxacin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000526	0.00461	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00052	0.00456	CcSEcCtD
Norfloxacin—Visual impairment—Cisplatin—esophageal cancer	0.000515	0.00452	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000513	0.0045	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000513	0.0045	CcSEcCtD
Norfloxacin—Tinnitus—Cisplatin—esophageal cancer	0.000498	0.00437	CcSEcCtD
Norfloxacin—Dysphagia—Capecitabine—esophageal cancer	0.000492	0.00432	CcSEcCtD
Norfloxacin—Photosensitivity—Methotrexate—esophageal cancer	0.000483	0.00423	CcSEcCtD
Norfloxacin—Hepatic failure—Methotrexate—esophageal cancer	0.000472	0.00414	CcSEcCtD
Norfloxacin—Erythema—Cisplatin—esophageal cancer	0.000465	0.00408	CcSEcCtD
Norfloxacin—Neutropenia—Capecitabine—esophageal cancer	0.00046	0.00404	CcSEcCtD
Norfloxacin—Flatulence—Cisplatin—esophageal cancer	0.000458	0.00402	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000449	0.00394	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000449	0.00394	CcSEcCtD
Norfloxacin—Visual disturbance—Methotrexate—esophageal cancer	0.000447	0.00392	CcSEcCtD
Norfloxacin—Muscle spasms—Cisplatin—esophageal cancer	0.000447	0.00392	CcSEcCtD
Norfloxacin—Vision blurred—Cisplatin—esophageal cancer	0.000438	0.00385	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000438	0.00384	CcSEcCtD
Norfloxacin—Tremor—Cisplatin—esophageal cancer	0.000436	0.00382	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000435	0.00382	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000433	0.00379	CcSEcCtD
Norfloxacin—Renal failure—Capecitabine—esophageal cancer	0.000431	0.00378	CcSEcCtD
Norfloxacin—Myocardial infarction—Capecitabine—esophageal cancer	0.00043	0.00377	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00043	0.00377	CcSEcCtD
Norfloxacin—Jaundice—Capecitabine—esophageal cancer	0.000428	0.00375	CcSEcCtD
Norfloxacin—Stomatitis—Capecitabine—esophageal cancer	0.000428	0.00375	CcSEcCtD
Norfloxacin—Conjunctivitis—Capecitabine—esophageal cancer	0.000426	0.00374	CcSEcCtD
Norfloxacin—Osteoarthritis—Methotrexate—esophageal cancer	0.000424	0.00372	CcSEcCtD
Norfloxacin—Haematuria—Capecitabine—esophageal cancer	0.000418	0.00367	CcSEcCtD
Norfloxacin—Leukopenia—Cisplatin—esophageal cancer	0.000416	0.00365	CcSEcCtD
Norfloxacin—Agranulocytosis—Capecitabine—esophageal cancer	0.000409	0.00359	CcSEcCtD
Norfloxacin—Irritability—Methotrexate—esophageal cancer	0.000405	0.00355	CcSEcCtD
Norfloxacin—Convulsion—Cisplatin—esophageal cancer	0.000403	0.00354	CcSEcCtD
Norfloxacin—Ataxia—Methotrexate—esophageal cancer	0.000399	0.0035	CcSEcCtD
Norfloxacin—Myalgia—Cisplatin—esophageal cancer	0.000396	0.00347	CcSEcCtD
Norfloxacin—Anxiety—Cisplatin—esophageal cancer	0.000395	0.00346	CcSEcCtD
Norfloxacin—Hepatitis—Capecitabine—esophageal cancer	0.000394	0.00346	CcSEcCtD
Norfloxacin—Levofloxacin—ABCB1—esophageal cancer	0.000392	0.127	CrCbGaD
Norfloxacin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000392	0.00344	CcSEcCtD
Norfloxacin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000391	0.00343	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000382	0.00335	CcSEcCtD
Norfloxacin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00038	0.00333	CcSEcCtD
Norfloxacin—Oedema—Cisplatin—esophageal cancer	0.00038	0.00333	CcSEcCtD
Norfloxacin—Visual impairment—Capecitabine—esophageal cancer	0.00038	0.00333	CcSEcCtD
Norfloxacin—Ciprofloxacin—ABCB1—esophageal cancer	0.000379	0.123	CrCbGaD
Norfloxacin—Erythema multiforme—Capecitabine—esophageal cancer	0.000372	0.00327	CcSEcCtD
Norfloxacin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000372	0.00326	CcSEcCtD
Norfloxacin—Tinnitus—Capecitabine—esophageal cancer	0.000367	0.00322	CcSEcCtD
Norfloxacin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000367	0.00322	CcSEcCtD
Norfloxacin—Eosinophilia—Methotrexate—esophageal cancer	0.000363	0.00318	CcSEcCtD
Norfloxacin—Anorexia—Cisplatin—esophageal cancer	0.000362	0.00317	CcSEcCtD
Norfloxacin—Pancreatitis—Methotrexate—esophageal cancer	0.000359	0.00315	CcSEcCtD
Norfloxacin—Chills—Capecitabine—esophageal cancer	0.000353	0.0031	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000346	0.00303	CcSEcCtD
Norfloxacin—Erythema—Capecitabine—esophageal cancer	0.000343	0.00301	CcSEcCtD
Norfloxacin—Neutropenia—Methotrexate—esophageal cancer	0.000343	0.00301	CcSEcCtD
Norfloxacin—Paraesthesia—Cisplatin—esophageal cancer	0.000341	0.00299	CcSEcCtD
Norfloxacin—Dyspnoea—Cisplatin—esophageal cancer	0.000338	0.00297	CcSEcCtD
Norfloxacin—Flatulence—Capecitabine—esophageal cancer	0.000338	0.00296	CcSEcCtD
Norfloxacin—Dysgeusia—Capecitabine—esophageal cancer	0.000336	0.00295	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000334	0.00293	CcSEcCtD
Norfloxacin—Back pain—Capecitabine—esophageal cancer	0.000332	0.00291	CcSEcCtD
Norfloxacin—Decreased appetite—Cisplatin—esophageal cancer	0.00033	0.0029	CcSEcCtD
Norfloxacin—Muscle spasms—Capecitabine—esophageal cancer	0.00033	0.00289	CcSEcCtD
Norfloxacin—Drowsiness—Methotrexate—esophageal cancer	0.000327	0.00287	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000324	0.00284	CcSEcCtD
Norfloxacin—Vision blurred—Capecitabine—esophageal cancer	0.000323	0.00283	CcSEcCtD
Norfloxacin—Tremor—Capecitabine—esophageal cancer	0.000321	0.00282	CcSEcCtD
Norfloxacin—Renal failure—Methotrexate—esophageal cancer	0.000321	0.00282	CcSEcCtD
Norfloxacin—Stomatitis—Methotrexate—esophageal cancer	0.000318	0.00279	CcSEcCtD
Norfloxacin—Conjunctivitis—Methotrexate—esophageal cancer	0.000317	0.00279	CcSEcCtD
Norfloxacin—Feeling abnormal—Cisplatin—esophageal cancer	0.000313	0.00274	CcSEcCtD
Norfloxacin—Haematuria—Methotrexate—esophageal cancer	0.000311	0.00273	CcSEcCtD
Norfloxacin—Vertigo—Capecitabine—esophageal cancer	0.000308	0.0027	CcSEcCtD
Norfloxacin—Leukopenia—Capecitabine—esophageal cancer	0.000307	0.00269	CcSEcCtD
Norfloxacin—Agranulocytosis—Methotrexate—esophageal cancer	0.000305	0.00267	CcSEcCtD
Norfloxacin—Palpitations—Capecitabine—esophageal cancer	0.000303	0.00266	CcSEcCtD
Norfloxacin—Body temperature increased—Cisplatin—esophageal cancer	0.0003	0.00263	CcSEcCtD
Norfloxacin—Hepatitis—Methotrexate—esophageal cancer	0.000293	0.00257	CcSEcCtD
Norfloxacin—Chest pain—Capecitabine—esophageal cancer	0.000292	0.00256	CcSEcCtD
Norfloxacin—Myalgia—Capecitabine—esophageal cancer	0.000292	0.00256	CcSEcCtD
Norfloxacin—Arthralgia—Capecitabine—esophageal cancer	0.000292	0.00256	CcSEcCtD
Norfloxacin—Anxiety—Capecitabine—esophageal cancer	0.000291	0.00255	CcSEcCtD
Norfloxacin—Dry mouth—Capecitabine—esophageal cancer	0.000285	0.0025	CcSEcCtD
Norfloxacin—Visual impairment—Methotrexate—esophageal cancer	0.000283	0.00248	CcSEcCtD
Norfloxacin—Confusional state—Capecitabine—esophageal cancer	0.000282	0.00248	CcSEcCtD
Norfloxacin—Oedema—Capecitabine—esophageal cancer	0.00028	0.00245	CcSEcCtD
Norfloxacin—Hypersensitivity—Cisplatin—esophageal cancer	0.00028	0.00245	CcSEcCtD
Norfloxacin—Erythema multiforme—Methotrexate—esophageal cancer	0.000277	0.00243	CcSEcCtD
Norfloxacin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000274	0.0024	CcSEcCtD
Norfloxacin—Tinnitus—Methotrexate—esophageal cancer	0.000273	0.0024	CcSEcCtD
Norfloxacin—Asthenia—Cisplatin—esophageal cancer	0.000272	0.00239	CcSEcCtD
Norfloxacin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000271	0.00237	CcSEcCtD
Norfloxacin—Anorexia—Capecitabine—esophageal cancer	0.000267	0.00234	CcSEcCtD
Norfloxacin—Chills—Methotrexate—esophageal cancer	0.000263	0.00231	CcSEcCtD
Norfloxacin—Diarrhoea—Cisplatin—esophageal cancer	0.00026	0.00228	CcSEcCtD
Norfloxacin—Erythema—Methotrexate—esophageal cancer	0.000255	0.00224	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000255	0.00224	CcSEcCtD
Norfloxacin—Insomnia—Capecitabine—esophageal cancer	0.000253	0.00222	CcSEcCtD
Norfloxacin—Paraesthesia—Capecitabine—esophageal cancer	0.000251	0.0022	CcSEcCtD
Norfloxacin—Dysgeusia—Methotrexate—esophageal cancer	0.00025	0.00219	CcSEcCtD
Norfloxacin—Dyspnoea—Capecitabine—esophageal cancer	0.000249	0.00219	CcSEcCtD
Norfloxacin—Back pain—Methotrexate—esophageal cancer	0.000247	0.00217	CcSEcCtD
Norfloxacin—Dyspepsia—Capecitabine—esophageal cancer	0.000246	0.00216	CcSEcCtD
Norfloxacin—Decreased appetite—Capecitabine—esophageal cancer	0.000243	0.00213	CcSEcCtD
Norfloxacin—Vomiting—Cisplatin—esophageal cancer	0.000241	0.00212	CcSEcCtD
Norfloxacin—Fatigue—Capecitabine—esophageal cancer	0.000241	0.00212	CcSEcCtD
Norfloxacin—Vision blurred—Methotrexate—esophageal cancer	0.000241	0.00211	CcSEcCtD
Norfloxacin—Rash—Cisplatin—esophageal cancer	0.000239	0.0021	CcSEcCtD
Norfloxacin—Constipation—Capecitabine—esophageal cancer	0.000239	0.0021	CcSEcCtD
Norfloxacin—Dermatitis—Cisplatin—esophageal cancer	0.000239	0.0021	CcSEcCtD
Norfloxacin—Feeling abnormal—Capecitabine—esophageal cancer	0.000231	0.00202	CcSEcCtD
Norfloxacin—Vertigo—Methotrexate—esophageal cancer	0.000229	0.00201	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000229	0.00201	CcSEcCtD
Norfloxacin—Leukopenia—Methotrexate—esophageal cancer	0.000228	0.002	CcSEcCtD
Norfloxacin—Nausea—Cisplatin—esophageal cancer	0.000225	0.00198	CcSEcCtD
Norfloxacin—Urticaria—Capecitabine—esophageal cancer	0.000222	0.00195	CcSEcCtD
Norfloxacin—Body temperature increased—Capecitabine—esophageal cancer	0.000221	0.00194	CcSEcCtD
Norfloxacin—Abdominal pain—Capecitabine—esophageal cancer	0.000221	0.00194	CcSEcCtD
Norfloxacin—Convulsion—Methotrexate—esophageal cancer	0.000221	0.00194	CcSEcCtD
Norfloxacin—Arthralgia—Methotrexate—esophageal cancer	0.000217	0.00191	CcSEcCtD
Norfloxacin—Chest pain—Methotrexate—esophageal cancer	0.000217	0.00191	CcSEcCtD
Norfloxacin—Myalgia—Methotrexate—esophageal cancer	0.000217	0.00191	CcSEcCtD
Norfloxacin—Confusional state—Methotrexate—esophageal cancer	0.00021	0.00184	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000208	0.00183	CcSEcCtD
Norfloxacin—Hypersensitivity—Capecitabine—esophageal cancer	0.000206	0.00181	CcSEcCtD
Norfloxacin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000204	0.00179	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000201	0.00177	CcSEcCtD
Norfloxacin—Asthenia—Capecitabine—esophageal cancer	0.000201	0.00176	CcSEcCtD
Norfloxacin—Anorexia—Methotrexate—esophageal cancer	0.000199	0.00174	CcSEcCtD
Norfloxacin—Pruritus—Capecitabine—esophageal cancer	0.000198	0.00174	CcSEcCtD
Norfloxacin—Diarrhoea—Capecitabine—esophageal cancer	0.000191	0.00168	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00019	0.00167	CcSEcCtD
Norfloxacin—Insomnia—Methotrexate—esophageal cancer	0.000188	0.00165	CcSEcCtD
Norfloxacin—Paraesthesia—Methotrexate—esophageal cancer	0.000187	0.00164	CcSEcCtD
Norfloxacin—Dyspnoea—Methotrexate—esophageal cancer	0.000186	0.00163	CcSEcCtD
Norfloxacin—Somnolence—Methotrexate—esophageal cancer	0.000185	0.00162	CcSEcCtD
Norfloxacin—Dizziness—Capecitabine—esophageal cancer	0.000185	0.00162	CcSEcCtD
Norfloxacin—Dyspepsia—Methotrexate—esophageal cancer	0.000183	0.00161	CcSEcCtD
Norfloxacin—Decreased appetite—Methotrexate—esophageal cancer	0.000181	0.00159	CcSEcCtD
Norfloxacin—Fatigue—Methotrexate—esophageal cancer	0.00018	0.00158	CcSEcCtD
Norfloxacin—Vomiting—Capecitabine—esophageal cancer	0.000178	0.00156	CcSEcCtD
Norfloxacin—Rash—Capecitabine—esophageal cancer	0.000176	0.00155	CcSEcCtD
Norfloxacin—Dermatitis—Capecitabine—esophageal cancer	0.000176	0.00155	CcSEcCtD
Norfloxacin—Headache—Capecitabine—esophageal cancer	0.000175	0.00154	CcSEcCtD
Norfloxacin—Feeling abnormal—Methotrexate—esophageal cancer	0.000172	0.00151	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00017	0.00149	CcSEcCtD
Norfloxacin—Nausea—Capecitabine—esophageal cancer	0.000166	0.00146	CcSEcCtD
Norfloxacin—Urticaria—Methotrexate—esophageal cancer	0.000165	0.00145	CcSEcCtD
Norfloxacin—Abdominal pain—Methotrexate—esophageal cancer	0.000165	0.00144	CcSEcCtD
Norfloxacin—Body temperature increased—Methotrexate—esophageal cancer	0.000165	0.00144	CcSEcCtD
Norfloxacin—Hypersensitivity—Methotrexate—esophageal cancer	0.000153	0.00135	CcSEcCtD
Norfloxacin—Asthenia—Methotrexate—esophageal cancer	0.000149	0.00131	CcSEcCtD
Norfloxacin—Pruritus—Methotrexate—esophageal cancer	0.000147	0.00129	CcSEcCtD
Norfloxacin—Diarrhoea—Methotrexate—esophageal cancer	0.000143	0.00125	CcSEcCtD
Norfloxacin—Dizziness—Methotrexate—esophageal cancer	0.000138	0.00121	CcSEcCtD
Norfloxacin—Vomiting—Methotrexate—esophageal cancer	0.000132	0.00116	CcSEcCtD
Norfloxacin—Rash—Methotrexate—esophageal cancer	0.000131	0.00115	CcSEcCtD
Norfloxacin—Dermatitis—Methotrexate—esophageal cancer	0.000131	0.00115	CcSEcCtD
Norfloxacin—Headache—Methotrexate—esophageal cancer	0.00013	0.00114	CcSEcCtD
Norfloxacin—Nausea—Methotrexate—esophageal cancer	0.000124	0.00109	CcSEcCtD
Norfloxacin—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	6.74e-05	0.000504	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	6.62e-05	0.000495	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CA1—esophageal cancer	6.53e-05	0.000488	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC10A2—esophageal cancer	6.53e-05	0.000488	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	6.53e-05	0.000488	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	6.42e-05	0.00048	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	6.41e-05	0.000479	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	6.38e-05	0.000477	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	6.34e-05	0.000474	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	6.22e-05	0.000465	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	6.21e-05	0.000464	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	6.21e-05	0.000464	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	6.15e-05	0.000459	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	6.14e-05	0.000459	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	6.07e-05	0.000454	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	6.07e-05	0.000454	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	6.01e-05	0.000449	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CA1—esophageal cancer	5.99e-05	0.000447	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC10A2—esophageal cancer	5.99e-05	0.000447	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CA2—esophageal cancer	5.97e-05	0.000446	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	5.96e-05	0.000446	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.9e-05	0.000441	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.7e-05	0.000426	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—EP300—esophageal cancer	5.56e-05	0.000416	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PLCE1—esophageal cancer	5.55e-05	0.000415	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ADH7—esophageal cancer	5.55e-05	0.000415	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—BLVRB—esophageal cancer	5.55e-05	0.000415	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC52A3—esophageal cancer	5.55e-05	0.000415	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	5.51e-05	0.000412	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—RB1—esophageal cancer	5.5e-05	0.000411	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CA2—esophageal cancer	5.47e-05	0.000409	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.47e-05	0.000409	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	5.45e-05	0.000407	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	5.4e-05	0.000404	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—BLVRB—esophageal cancer	5.24e-05	0.000392	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC52A3—esophageal cancer	5.24e-05	0.000392	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.11e-05	0.000382	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PLCE1—esophageal cancer	5.09e-05	0.00038	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ADH7—esophageal cancer	5.09e-05	0.00038	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	5.04e-05	0.000376	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ADH1B—esophageal cancer	4.87e-05	0.000364	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.85e-05	0.000362	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	4.83e-05	0.000361	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	4.8e-05	0.000359	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	4.74e-05	0.000354	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC10A2—esophageal cancer	4.72e-05	0.000353	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CA1—esophageal cancer	4.72e-05	0.000353	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.69e-05	0.00035	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TYMP—esophageal cancer	4.65e-05	0.000348	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	4.56e-05	0.000341	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP26A1—esophageal cancer	4.53e-05	0.000338	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ADH1B—esophageal cancer	4.46e-05	0.000333	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC10A2—esophageal cancer	4.46e-05	0.000333	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA1—esophageal cancer	4.46e-05	0.000333	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	4.42e-05	0.00033	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALOX15—esophageal cancer	4.41e-05	0.00033	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CA2—esophageal cancer	4.32e-05	0.000323	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.31e-05	0.000322	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TYMP—esophageal cancer	4.26e-05	0.000319	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TPI1—esophageal cancer	4.21e-05	0.000314	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTO1—esophageal cancer	4.21e-05	0.000314	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	4.2e-05	0.000314	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP26A1—esophageal cancer	4.15e-05	0.00031	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND1—esophageal cancer	4.08e-05	0.000305	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA2—esophageal cancer	4.08e-05	0.000305	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALOX15—esophageal cancer	4.04e-05	0.000302	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALDOB—esophageal cancer	4.03e-05	0.000301	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PLCE1—esophageal cancer	4.01e-05	0.0003	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADH7—esophageal cancer	4.01e-05	0.0003	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.99e-05	0.000298	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	3.95e-05	0.000295	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GAPDH—esophageal cancer	3.88e-05	0.00029	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TPI1—esophageal cancer	3.86e-05	0.000288	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTO1—esophageal cancer	3.86e-05	0.000288	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CRABP1—esophageal cancer	3.85e-05	0.000288	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PLCE1—esophageal cancer	3.79e-05	0.000283	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADH7—esophageal cancer	3.79e-05	0.000283	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.76e-05	0.000281	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—EP300—esophageal cancer	3.76e-05	0.000281	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	3.75e-05	0.00028	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.75e-05	0.00028	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALDOB—esophageal cancer	3.7e-05	0.000276	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	3.66e-05	0.000274	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GNG7—esophageal cancer	3.66e-05	0.000274	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.66e-05	0.000273	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GAPDH—esophageal cancer	3.56e-05	0.000266	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CRABP1—esophageal cancer	3.53e-05	0.000264	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADH1B—esophageal cancer	3.52e-05	0.000263	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALDH2—esophageal cancer	3.43e-05	0.000256	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TYMP—esophageal cancer	3.36e-05	0.000251	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GNG7—esophageal cancer	3.36e-05	0.000251	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	3.34e-05	0.00025	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—BLVRB—esophageal cancer	3.34e-05	0.00025	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADH1B—esophageal cancer	3.32e-05	0.000248	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—esophageal cancer	3.27e-05	0.000245	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP26A1—esophageal cancer	3.27e-05	0.000244	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTT1—esophageal cancer	3.26e-05	0.000244	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP2A6—esophageal cancer	3.22e-05	0.000241	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALOX15—esophageal cancer	3.19e-05	0.000238	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TYMP—esophageal cancer	3.18e-05	0.000237	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALDH2—esophageal cancer	3.14e-05	0.000235	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP26A1—esophageal cancer	3.09e-05	0.000231	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS1—esophageal cancer	3.06e-05	0.000228	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ENO1—esophageal cancer	3.06e-05	0.000228	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TPI1—esophageal cancer	3.04e-05	0.000227	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTO1—esophageal cancer	3.04e-05	0.000227	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PSME2—esophageal cancer	3.01e-05	0.000225	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PSME1—esophageal cancer	3.01e-05	0.000225	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALOX15—esophageal cancer	3.01e-05	0.000225	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTT1—esophageal cancer	2.99e-05	0.000223	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.99e-05	0.000223	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALDOB—esophageal cancer	2.92e-05	0.000218	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTO1—esophageal cancer	2.87e-05	0.000215	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TPI1—esophageal cancer	2.87e-05	0.000215	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA1—esophageal cancer	2.84e-05	0.000212	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.84e-05	0.000212	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GAPDH—esophageal cancer	2.81e-05	0.00021	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ENO1—esophageal cancer	2.8e-05	0.000209	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS1—esophageal cancer	2.8e-05	0.000209	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CRABP1—esophageal cancer	2.78e-05	0.000208	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PSME1—esophageal cancer	2.76e-05	0.000206	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PSME2—esophageal cancer	2.76e-05	0.000206	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALDOB—esophageal cancer	2.75e-05	0.000206	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—esophageal cancer	2.69e-05	0.000201	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GAPDH—esophageal cancer	2.65e-05	0.000198	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GNG7—esophageal cancer	2.65e-05	0.000198	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CRABP1—esophageal cancer	2.63e-05	0.000196	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA2—esophageal cancer	2.6e-05	0.000194	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP1B1—esophageal cancer	2.6e-05	0.000194	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.58e-05	0.000193	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.58e-05	0.000193	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.54e-05	0.00019	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GNG7—esophageal cancer	2.5e-05	0.000187	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALDH2—esophageal cancer	2.48e-05	0.000185	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP19A1—esophageal cancer	2.44e-05	0.000183	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.42e-05	0.000181	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADH7—esophageal cancer	2.42e-05	0.000181	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.39e-05	0.000179	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP1B1—esophageal cancer	2.38e-05	0.000178	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTT1—esophageal cancer	2.36e-05	0.000176	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALDH2—esophageal cancer	2.34e-05	0.000175	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	2.33e-05	0.000174	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP19A1—esophageal cancer	2.24e-05	0.000167	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—HMOX1—esophageal cancer	2.23e-05	0.000167	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTT1—esophageal cancer	2.23e-05	0.000166	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS1—esophageal cancer	2.21e-05	0.000165	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ENO1—esophageal cancer	2.21e-05	0.000165	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2A6—esophageal cancer	2.2e-05	0.000165	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.19e-05	0.000164	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA1—esophageal cancer	2.19e-05	0.000164	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.19e-05	0.000164	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PSME2—esophageal cancer	2.18e-05	0.000163	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PSME1—esophageal cancer	2.18e-05	0.000163	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ABCB1—esophageal cancer	2.14e-05	0.00016	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.12e-05	0.000158	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS1—esophageal cancer	2.09e-05	0.000156	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ENO1—esophageal cancer	2.09e-05	0.000156	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSME2—esophageal cancer	2.06e-05	0.000154	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSME1—esophageal cancer	2.06e-05	0.000154	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HMOX1—esophageal cancer	2.04e-05	0.000153	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TYMP—esophageal cancer	2.03e-05	0.000151	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA2—esophageal cancer	2.01e-05	0.00015	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.97e-05	0.000147	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.96e-05	0.000147	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.92e-05	0.000144	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.88e-05	0.00014	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.87e-05	0.000139	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADH7—esophageal cancer	1.87e-05	0.000139	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TPI1—esophageal cancer	1.83e-05	0.000137	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.83e-05	0.000137	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.8e-05	0.000134	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP1B1—esophageal cancer	1.78e-05	0.000133	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.77e-05	0.000132	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.76e-05	0.000131	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.69e-05	0.000126	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.68e-05	0.000125	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP19A1—esophageal cancer	1.67e-05	0.000125	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.64e-05	0.000122	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.61e-05	0.00012	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GNG7—esophageal cancer	1.59e-05	0.000119	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TYMP—esophageal cancer	1.56e-05	0.000117	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.55e-05	0.000116	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HMOX1—esophageal cancer	1.52e-05	0.000114	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.52e-05	0.000114	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.49e-05	0.000112	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.49e-05	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.48e-05	0.000111	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCB1—esophageal cancer	1.46e-05	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CREBBP—esophageal cancer	1.43e-05	0.000107	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.42e-05	0.000106	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.41e-05	0.000106	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TPI1—esophageal cancer	1.41e-05	0.000106	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.4e-05	0.000105	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.4e-05	0.000105	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.36e-05	0.000101	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.33e-05	9.95e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ENO1—esophageal cancer	1.33e-05	9.95e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSME1—esophageal cancer	1.31e-05	9.8e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSME2—esophageal cancer	1.31e-05	9.8e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CREBBP—esophageal cancer	1.31e-05	9.8e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.3e-05	9.75e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.29e-05	9.66e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NOS3—esophageal cancer	1.28e-05	9.57e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GNG7—esophageal cancer	1.23e-05	9.19e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NOS3—esophageal cancer	1.17e-05	8.77e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—esophageal cancer	1.17e-05	8.75e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.15e-05	8.61e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.15e-05	8.56e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.13e-05	8.46e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.11e-05	8.26e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.1e-05	8.19e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.08e-05	8.1e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—esophageal cancer	1.07e-05	8.02e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.06e-05	7.95e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.03e-05	7.73e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ENO1—esophageal cancer	1.03e-05	7.68e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.03e-05	7.68e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSME1—esophageal cancer	1.01e-05	7.57e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSME2—esophageal cancer	1.01e-05	7.57e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CREBBP—esophageal cancer	9.77e-06	7.3e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—EP300—esophageal cancer	9.74e-06	7.28e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HMOX1—esophageal cancer	9.71e-06	7.26e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.53e-06	7.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCB1—esophageal cancer	9.32e-06	6.97e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NOS3—esophageal cancer	9.26e-06	6.92e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—EP300—esophageal cancer	8.93e-06	6.67e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NOS3—esophageal cancer	8.75e-06	6.54e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	8.74e-06	6.53e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—esophageal cancer	8.47e-06	6.33e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.21e-06	6.14e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—esophageal cancer	8e-06	5.98e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.5e-06	5.6e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CA—esophageal cancer	7.21e-06	5.39e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.19e-06	5.38e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.05e-06	5.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—EP300—esophageal cancer	7.04e-06	5.26e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—EP300—esophageal cancer	6.65e-06	4.97e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CA—esophageal cancer	6.61e-06	4.94e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.23e-06	4.66e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NOS3—esophageal cancer	5.58e-06	4.17e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	5.21e-06	3.89e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.1e-06	3.81e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CA—esophageal cancer	4.92e-06	3.68e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.81e-06	3.59e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NOS3—esophageal cancer	4.3e-06	3.22e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—EP300—esophageal cancer	4.24e-06	3.17e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.94e-06	2.94e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—EP300—esophageal cancer	3.27e-06	2.45e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.14e-06	2.35e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.42e-06	1.81e-05	CbGpPWpGaD
